prednisolone has been researched along with Uveitis, Anterior in 143 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Uveitis, Anterior: Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.
Excerpt | Relevance | Reference |
---|---|---|
"To compare the outcomes of congenital cataract surgery using intraoperative intracameral triamcinolone versus postoperative oral prednisolone to modulate ocular inflammation." | 9.19 | Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. ( Arantes, TE; Nosé, W; Ventura, BV; Ventura, CV; Ventura, LO; Ventura, MC, 2014) |
"The results indicate that equivalent control of inflammation can be obtained through treatment with loteprednol etabonate or prednisolone acetate after cataract surgery." | 9.17 | Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. ( Holland, EJ; Lane, SS, 2013) |
"Rimexolone 1% ophthalmic suspension is both an effective and safe topical steroid in controlling postoperative inflammation after cataract extraction with phacoemulsification." | 9.11 | Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery. ( Ozbay, D; Ozden, S; Tatlipinar, S; Yaylali, V; Yildirim, C, 2004) |
" Safety included evaluation of adverse events." | 6.82 | Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. ( Gedif, K; Lambert, SR; Markwardt, K; O'Halloran, H; Plager, DA; Roarty, J; VanderVeen, D; Wilson, ME, 2016) |
"To compare the outcomes of congenital cataract surgery using intraoperative intracameral triamcinolone versus postoperative oral prednisolone to modulate ocular inflammation." | 5.19 | Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. ( Arantes, TE; Nosé, W; Ventura, BV; Ventura, CV; Ventura, LO; Ventura, MC, 2014) |
"The results indicate that equivalent control of inflammation can be obtained through treatment with loteprednol etabonate or prednisolone acetate after cataract surgery." | 5.17 | Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. ( Holland, EJ; Lane, SS, 2013) |
"In this high-dose pulsed-therapy regimen, difluprednate reduced inflammation more effectively than prednisolone acetate, resulting in more rapid return of vision." | 5.15 | A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. ( Donnenfeld, ED; Fiore, J; Gobbo, A; Holland, EJ; Perry, HD; Prince, J; Sandoval, HP; Shull, ER; Solomon, KD, 2011) |
"Rimexolone 1% ophthalmic suspension is both an effective and safe topical steroid in controlling postoperative inflammation after cataract extraction with phacoemulsification." | 5.11 | Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery. ( Ozbay, D; Ozden, S; Tatlipinar, S; Yaylali, V; Yildirim, C, 2004) |
"To compare the effects of a topical nonsteroidal anti-inflammatory agent, diclofenac, and prednisolone acetate on wound healing, postoperative inflammation, and other clinical parameters in laser in situ keratomileusis (LASIK) patients." | 5.09 | Effects of topical diclofenac and prednisolone eyedrops in laser in situ keratomileusis patients. ( Juárez, CP; Luna, JD; Muiño, JC; Vantesone, DL, 1999) |
"This study shows that following trabeculectomy with adjunctive mitomycin-C, a similar intraocular pressure result may be expected when either diclofenac or prednisolone acetate is prescribed postoperatively for intraocular inflammation." | 5.08 | The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. ( Cate, EA; Dubiner, HB; Kent, AR; Mundorf, TK; Stewart, JA; Stewart, WC; Whitaker, R, 1998) |
" A diagnosis of oleander-associated ocular inflammation with secondary corneal edema was made, given the temporal relationship, and treatment was initiated with topical prednisolone and cyclopentolate." | 4.12 | Oleander-Associated Keratitis and Uveitis. ( Baratz, KH; Farazdaghi, MK; Patel, SV; Tailor, PD, 2022) |
"The case concerns an 81-year-old woman on treatment with a topical fixed combination of timolol and brimonidine who was diagnosed in the Emergency Department with acute anterior granulomatous hypertensive uveitis." | 3.88 | Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine. ( Arciniegas-Perasso, CA; Clemente-Tomás, R; Duch-Samper, AM; García-Ibor, F; Hervás-Hernandis, JM; Ruiz-Del Río, N, 2018) |
" Ocular inflammation presented as episcleritis, scleritis, or anterior uveitis, and it emerged during the tapering of low-dose prednisolone prescribed for polymyalgia rheumatica in all patients." | 3.88 | Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: A Report of Three Cases. ( Arai, T; Kaburaki, T; Tanaka, R, 2018) |
"A 38-year-old woman suffered from bilateral acute anterior uveitis, manifesting 12-24 h after application of an analgesic capsaicin patch (Isola Capsicum N Plus) that served to alleviate muscular neck pain." | 3.79 | Association of bilateral acute anterior uveitis with a capsaicin patch. ( Bleuel, I; Tappeiner, C; Tschopp, M; Zinkernagel, M, 2013) |
" One week after beginning systemic application of acyclovir (5 x 800 mg daily) and prednisolone (30 mg daily), the anterior chamber inflammation regressed and a fibrosis seemed to appear in the atrophic scleral area." | 3.74 | [Scleromalacia associated with varicella-zoster virus]. ( Deuter, CM; Szurman, P; Tatar, O; Yoeruek, E; Zierhut, M, 2008) |
"Anterior uveitis was produced in the rabbit eye by introducing a standardized clove oil globule into the anterior chamber." | 3.66 | Quantitation of anterior chamber inflammation and its response to therapy. ( Bolliger, GA; Kupferman, A; Leibowitz, HM, 1980) |
" Safety included evaluation of adverse events." | 2.82 | Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. ( Gedif, K; Lambert, SR; Markwardt, K; O'Halloran, H; Plager, DA; Roarty, J; VanderVeen, D; Wilson, ME, 2016) |
"The intraocular pressures were measured at regular intervals during the 6-months follow-up period." | 2.80 | Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty. ( Anctil, JL; Champagne, S; Des Marchais, B; Goyette, A; Lajoie, C, 2015) |
"Ocular lesions, the main morbidity of Behcet's disease (BD), are the most difficult to treat." | 2.75 | Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study). ( Akhlaghi, M; Chams-Davatchi, C; Davatchi, F; Faezi, T; Naderi, N; Nadji, A; Rezaipoor, M; Sadeghi-Abdollahi, B; Shahram, F; Shams, H, 2010) |
" Difluprednate provides effective treatment for anterior uveitis and requires less frequent dosing than prednisolone acetate." | 2.75 | Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. ( Crockett, RS; Davanzo, R; Flynn, TE; Foster, CS; McLeod, K; Vogel, R, 2010) |
"Intraocular pressure was increased regularly." | 2.69 | Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group. ( , 1999) |
" No adverse events were reported, and there were no significant changes in intraocular pressure in either group." | 2.69 | Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. ( Jenkins, JE; Pendelton, RA; Simone, JN, 1999) |
"Ocular complications in ulcerative colitis has been reviewed." | 2.40 | [Ocular complications in ulcerative colitis]. ( Harada, T, 1999) |
"We report a case of confirmed Mycoplasma pneumoniae infection in the setting of unilateral anterior uveitis and perineuritis without coexisting systemic manifestations." | 1.43 | Acute Mycoplasma pneumoniae infection presenting with unilateral anterior uveitis and perineuritis. ( Chen, WS; Perry, JT, 2016) |
"Azathioprine was used at 2-3 mg/kg daily." | 1.40 | Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years. ( Akhlaghi, M; Ashofteh, F; Chams-Davatchi, C; Davatchi, F; Faezi, T; Ghodsi, Z; Mohtasham, N; Nadji, A; Sadeghi Abdollahi, B; Shahram, F; Shams, H, 2014) |
"Prednisolone was added at 0." | 1.39 | Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years. ( Akhlaghi, M; Ashofteh, F; Chams-Davatchi, C; Davatchi, F; Faezi, T; Nadji, A; Sadeghi Abdollahi, B; Shahram, F; Shams, H, 2013) |
"Cystoid macular edema is a major complication in uveitis." | 1.38 | Long-term follow-up of inflammatory cystoid macular edema. ( Asteriades, S; Pavesio, CE; Tranos, PG; Tsaousis, KT; Vakalis, AN, 2012) |
"The role of streptococcal infections in the development of uveitis remains uncertain." | 1.37 | [Post-streptococcal uveitis]. ( Caspers, L; Catherine, J; Judice, M; Kolyvras, N; Relvas, L; Viel, A; Willermain, F, 2011) |
"At the first recurrence, 81% (13 patients) of exudative retinal detachments (ERD) were associated with an initial immunomodulatory treatment conducted ≤6 months (3." | 1.37 | Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease. ( Bodaghi, B; Cohen, D; Errera, MH; Fardeau, C; Gaudric, A; LeHoang, P; Navarro, A; Westcott, M, 2011) |
"To report on the occurrence of tubulointerstitial nephritis and uveitis (TINU) and HLA typing in two siblings." | 1.36 | Tubulointerstitial nephritis and uveitis in siblings. ( Altpeter, E; Biester, S; Deuter, CM; Doycheva, D; Müller, C; Zierhut, M, 2010) |
" However, chronic use of topical corticosteroids dosed at < or = 3 drops daily seemed to be associated with a lower risk of cataract development relative to eyes receiving higher doses over follow-up in the setting of suppressed uveitis." | 1.36 | Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. ( Dunn, JP; Jabs, DA; Thorne, JE; Woreta, FA, 2010) |
"In cases of skin rash and recurrent anterior uveitis, HSV should be considered in the differential diagnosis." | 1.36 | Recurrent anterior uveitis in Henoch Schonlein's vasculitis. ( Aral, O; Cingu, K; Erer, B; Gul, A; Inanc, M; Kamali, S; Kilicaslan, I; Tugal-Tutkun, I, 2010) |
"Mild anterior uveitis is an unfamiliar adverse effect of pamidronate therapy." | 1.34 | Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost. ( Palimar, P; Quah, S; Ramasamy, B; Sahni, JN, 2007) |
"Treatment with fucoxanthin resulted in a reduction in PGE2, NO and TNF-alpha concentrations in the aqueous humour." | 1.33 | Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. ( Ilieva, I; Jin, XH; Kase, S; Koyama, Y; Miyashita, K; Ohgami, K; Ohno, S; Shiratori, K; Yoshida, K, 2005) |
"Idiopathic tubulointerstitial nephritis and uveitis (TINU) syndrome is an uncommon condition, characterized by acute tubulointerstitial nephritis (TIN) with a favorable course and uveitis with a chronic relapsing course." | 1.33 | A case of tubulointerstitial nephritis and uveitis syndrome with severe immunologic dysregulation. ( Kim, HJ; Lee, JW; Lee, SJ; Sung, SH, 2005) |
"To describe a case of Langerhans cell histiocytosis (LCH) that involved the anterior uveal tract." | 1.33 | Anterior uveitis and iris nodules that are associated with Langerhans cell histiocytosis. ( Ching, SS; Galaydh, F; Tsai, JH, 2005) |
"Uveitis in association with tubulointerstitial nephritis is a distinct clinical entity known as tubulointerstitial nephritis and uveitis(TINU) syndrome." | 1.32 | Tubulointerstitial nephritis and uveitis syndrome. ( Austin, JK; Johnson, BS; Pizio, HF, 2003) |
"We describe an unusual case of Takayasu's arteritis presenting in a child who complained of painful blurred vision." | 1.32 | Anterior uveitis in a child with Takayasu's arteritis. ( Favilla, I; McDonald, MA; Ojaimi, E, 2004) |
"The CREST syndrome is a variant form of progressive systemic sclerosis." | 1.31 | Granulomatous anterior uveitis in a patient with CREST syndrome. ( Akman, A; Akova, YA; Aydin, P; Yücel, E, 2000) |
"Anterior uveitis was induced in one eye of eight rabbits by subcutaneous injection of Mycobacterium tuberculosis, followed after 10 days with intravitreal challenge." | 1.31 | Evaluation of therapeutic effectiveness using MR imaging in a rabbit model of anterior uveitis. ( Freddo, TF; Goode, ST; Kolodny, NH; Ryan, W, 2002) |
"Four children, 4 to 10 years old, with chronic uveitis were treated with cyclosporin A (CsA; starting dosage 2 mg/kg per day) and prednisolone." | 1.29 | [Cyclosporin A in therapy of chronic uveitis in childhood]. ( Dannecker, G; Schlote, T; Thiel, HJ; Zierhut, M, 1996) |
"Posterior uveitis was induced by injection of 10 micrograms endotoxin intravitreally into rat eyes and anterior ocular inflammation was induced by injection of 0." | 1.28 | Inhibition of ocular inflammation by chalcone derivatives and prednisolone. ( Chiou, GC; Varma, RS; Yao, QS, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (13.29) | 18.7374 |
1990's | 18 (12.59) | 18.2507 |
2000's | 48 (33.57) | 29.6817 |
2010's | 52 (36.36) | 24.3611 |
2020's | 6 (4.20) | 2.80 |
Authors | Studies |
---|---|
Tailor, PD | 1 |
Farazdaghi, MK | 1 |
Patel, SV | 1 |
Baratz, KH | 1 |
Sheppard, J | 2 |
Garg, S | 1 |
Lievens, C | 1 |
Brandano, L | 1 |
Wirostko, B | 1 |
Korenfeld, M | 1 |
Raizman, M | 1 |
Foster, CS | 5 |
Ozturk, T | 1 |
Arikan, G | 1 |
Oner, H | 1 |
Mandell, KJ | 1 |
Clark, D | 1 |
Chu, DS | 1 |
Brady, TC | 1 |
Moksha, L | 1 |
Halder, N | 1 |
Singh, SB | 1 |
Chawla, R | 1 |
Kumar, A | 1 |
Velpandian, T | 1 |
Wong Chung, JERE | 1 |
Engin, Ö | 1 |
Wolfs, TFW | 1 |
Renson, TJC | 1 |
de Boer, JH | 1 |
Al-Amry, MA | 1 |
Alsulaiman, SM | 1 |
Ghazi, NG | 1 |
Tamborrini, G | 1 |
Moser, F | 1 |
Sterki Novakova, K | 1 |
Clemente-Tomás, R | 1 |
Arciniegas-Perasso, CA | 1 |
Hervás-Hernandis, JM | 1 |
García-Ibor, F | 1 |
Ruiz-Del Río, N | 1 |
Duch-Samper, AM | 1 |
Balci, O | 1 |
Tanriverdi, C | 1 |
Aydin, A | 1 |
Ozsutcu, M | 1 |
Gulkilik, G | 1 |
Kocabora, MS | 1 |
Kim, EC | 1 |
Lee, SJ | 2 |
Hwang, HS | 1 |
Kim, J | 1 |
Kim, MS | 1 |
Lane, SS | 2 |
Holland, EJ | 3 |
Özyol, E | 1 |
Özyol, P | 1 |
Bleuel, I | 1 |
Zinkernagel, M | 1 |
Tschopp, M | 1 |
Tappeiner, C | 1 |
Stanca, HT | 1 |
Duong, HV | 1 |
Westfield, KC | 1 |
Singleton, IC | 1 |
Sandmeyer, LS | 1 |
Bauer, BS | 1 |
Grahn, BH | 1 |
Davatchi, F | 4 |
Shams, H | 3 |
Shahram, F | 4 |
Nadji, A | 4 |
Chams-Davatchi, C | 3 |
Sadeghi Abdollahi, B | 2 |
Faezi, T | 3 |
Akhlaghi, M | 3 |
Ashofteh, F | 2 |
Elbialy, NS | 1 |
Abdol-Azim, BM | 1 |
Shafaa, MW | 1 |
El Shazly, LH | 1 |
El Shazly, AH | 1 |
Khalil, WA | 1 |
Ghodsi, Z | 1 |
Mohtasham, N | 1 |
Hedayatfar, A | 1 |
Hashemi, H | 1 |
Asgari, S | 1 |
Chee, SP | 2 |
Ventura, MC | 1 |
Ventura, BV | 1 |
Ventura, CV | 1 |
Ventura, LO | 1 |
Arantes, TE | 1 |
Nosé, W | 1 |
Sheppard, JD | 2 |
Toyos, MM | 1 |
Kempen, JH | 1 |
Kaur, P | 1 |
Kirkwood, BJ | 1 |
Takkar, B | 1 |
Chandra, P | 1 |
Kumar, K | 1 |
Vanathi, M | 1 |
Miserocchi, E | 1 |
Cimminiello, C | 1 |
Mazzola, M | 1 |
Russo, V | 1 |
Modorati, GM | 1 |
Champagne, S | 1 |
Anctil, JL | 1 |
Goyette, A | 1 |
Lajoie, C | 1 |
Des Marchais, B | 1 |
Gondchawar, A | 1 |
Biswas, J | 3 |
Murali, S | 1 |
Eawaran, LM | 1 |
Grixti, A | 1 |
Hagan, R | 1 |
Nayak, H | 1 |
Chandna, A | 1 |
Perry, JT | 1 |
Chen, WS | 1 |
Wilson, ME | 1 |
O'Halloran, H | 1 |
VanderVeen, D | 1 |
Roarty, J | 1 |
Plager, DA | 1 |
Markwardt, K | 1 |
Gedif, K | 1 |
Lambert, SR | 1 |
Ganapathy, PS | 1 |
Lowder, CY | 2 |
Srivastava, SK | 1 |
Pal, S | 1 |
Karagiannis, G | 1 |
Dubrey, SW | 1 |
Arai, T | 1 |
Tanaka, R | 1 |
Kaburaki, T | 1 |
Sorrell, MS | 1 |
Taylor, KH | 1 |
Fish, RE | 1 |
Besada, E | 1 |
Frauens, BJ | 1 |
Wickremasinghe, SS | 1 |
Stawell, R | 1 |
Lim, L | 1 |
Pakrou, N | 1 |
Zamir, E | 1 |
Hanno, E | 1 |
Gay, D | 1 |
Boyer, S | 1 |
Paganelli, F | 2 |
Cardillo, JA | 2 |
Melo, LA | 2 |
Lucena, DR | 1 |
Silva, AA | 1 |
Oliveira, AG | 2 |
Höfling-Lima, AL | 1 |
Nguyen, QD | 1 |
Kuppermann, BD | 1 |
Belfort, R | 1 |
Sungur, GK | 1 |
Hazirolan, D | 1 |
Yalvac, IS | 1 |
Ozer, PA | 1 |
Aslan, BS | 1 |
Duman, S | 1 |
Jetton, J | 1 |
Gaviria, JG | 1 |
Patterson, TF | 1 |
Johnson, DA | 1 |
Erer, B | 1 |
Kamali, S | 1 |
Cingu, K | 1 |
Kilicaslan, I | 1 |
Gul, A | 1 |
Inanc, M | 1 |
Aral, O | 1 |
Tugal-Tutkun, I | 1 |
Pang, CE | 1 |
Teoh, SC | 1 |
Thorne, JE | 1 |
Woreta, FA | 1 |
Dunn, JP | 1 |
Jabs, DA | 1 |
Hossain, MM | 1 |
Mohiuddin, AA | 1 |
Hossain, MA | 1 |
Aziz, MA | 1 |
Biester, S | 1 |
Müller, C | 1 |
Deuter, CM | 2 |
Doycheva, D | 1 |
Altpeter, E | 1 |
Zierhut, M | 3 |
Rezaipoor, M | 1 |
Sadeghi-Abdollahi, B | 1 |
Naderi, N | 1 |
Davanzo, R | 1 |
Flynn, TE | 1 |
McLeod, K | 1 |
Vogel, R | 1 |
Crockett, RS | 1 |
Cleary, CA | 1 |
Lanigan, B | 1 |
O'Keeffe, M | 1 |
Fintelmann, RE | 1 |
Qian, Y | 1 |
Skalet, A | 1 |
Jeng, BH | 1 |
Errera, MH | 1 |
Fardeau, C | 1 |
Cohen, D | 1 |
Navarro, A | 1 |
Gaudric, A | 1 |
Bodaghi, B | 1 |
Westcott, M | 1 |
LeHoang, P | 1 |
Antlanger, M | 1 |
Shaw, SJ | 1 |
Kurup, SK | 1 |
Viel, A | 1 |
Kolyvras, N | 1 |
Catherine, J | 1 |
Relvas, L | 1 |
Judice, M | 1 |
Caspers, L | 1 |
Willermain, F | 1 |
Varner, P | 1 |
Jap, A | 1 |
Donnenfeld, ED | 1 |
Solomon, KD | 2 |
Fiore, J | 1 |
Gobbo, A | 1 |
Prince, J | 1 |
Sandoval, HP | 1 |
Shull, ER | 1 |
Perry, HD | 1 |
Lai, CC | 1 |
Chang, YS | 1 |
Li, ML | 1 |
Chang, CM | 1 |
Huang, FC | 1 |
Tseng, SH | 1 |
Altan-Yaycioglu, R | 1 |
Canan, H | 1 |
Akova, YA | 2 |
Tranos, PG | 1 |
Tsaousis, KT | 1 |
Vakalis, AN | 1 |
Asteriades, S | 1 |
Pavesio, CE | 1 |
Sham, CW | 1 |
Levinson, RD | 1 |
Koktekir, BE | 1 |
Gedik, S | 1 |
Bakbak, B | 1 |
Belliveau, MJ | 1 |
Almeida, DR | 1 |
Urton, TE | 1 |
Kim, GT | 1 |
Pereira, DV | 1 |
Petronilho, F | 1 |
Pereira, HR | 1 |
Vuolo, F | 1 |
Mina, F | 1 |
Possato, JC | 1 |
Vitto, MF | 1 |
de Souza, DR | 1 |
da Silva, L | 1 |
da Silva Paula, MM | 1 |
de Souza, CT | 1 |
Dal-Pizzol, F | 1 |
Salim, A | 1 |
Williamson, M | 1 |
Barker, F | 1 |
Hughes, J | 1 |
Tekeli, O | 1 |
Ozdemir, O | 1 |
Song, A | 1 |
Dubovy, SR | 1 |
Berrocal, AM | 1 |
Murray, T | 1 |
Baltatzis, S | 1 |
Romero-Rangel, T | 1 |
Bains, HS | 1 |
Jampol, LM | 1 |
Caughron, MC | 1 |
Parnell, JR | 1 |
Naseri, A | 1 |
Good, WV | 1 |
Cunningham, ET | 1 |
Narayana, KM | 1 |
Agrawal, R | 1 |
Arjundas, D | 1 |
Johnson, BS | 1 |
Austin, JK | 1 |
Pizio, HF | 1 |
Meyer, CH | 1 |
Sel, S | 1 |
Hörle, S | 1 |
Burg, J | 1 |
Kroll, P | 1 |
Ohgami, K | 3 |
Shiratori, K | 3 |
Kotake, S | 1 |
Nishida, T | 1 |
Mizuki, N | 1 |
Yazawa, K | 1 |
Ohno, S | 3 |
Chams, H | 1 |
Jamshidi, A | 1 |
Akbarian, M | 1 |
Gharibdoost, F | 1 |
Yaylali, V | 1 |
Ozbay, D | 1 |
Tatlipinar, S | 1 |
Yildirim, C | 1 |
Ozden, S | 1 |
McDonald, MA | 1 |
Ojaimi, E | 1 |
Favilla, I | 1 |
Taylor, S | 1 |
Lightman, S | 2 |
Becker, HI | 1 |
Walton, RC | 1 |
Diamant, JI | 1 |
Zegans, ME | 1 |
Skaf, M | 1 |
Costa, RA | 1 |
Curi, A | 3 |
Matos, K | 3 |
Pavesio, C | 3 |
Ilieva, I | 2 |
Koyama, Y | 2 |
Jin, XH | 2 |
Yoshida, K | 2 |
Kase, S | 2 |
Kitaichi, N | 1 |
Suzuki, Y | 1 |
Tanaka, T | 1 |
Samudre, SS | 1 |
Lattanzio, FA | 1 |
Williams, PB | 1 |
Hirneiss, C | 1 |
Neubauer, AS | 1 |
Kampik, A | 1 |
Schönfeld, CL | 1 |
Ganeshbabu, TM | 1 |
Raghavendran, SR | 1 |
Raizada, S | 1 |
Mondkar, SV | 1 |
Madhavan, HN | 1 |
Miyashita, K | 2 |
McLeod, SD | 1 |
Mather, R | 1 |
Hwang, DG | 1 |
Margolis, TP | 1 |
Lee, JW | 1 |
Kim, HJ | 1 |
Sung, SH | 1 |
Chiang, MY | 1 |
Sarkar, M | 1 |
Koppens, JM | 1 |
Milles, J | 1 |
Shah, P | 1 |
Tsai, JH | 1 |
Galaydh, F | 1 |
Ching, SS | 1 |
Sato, T | 1 |
Tsuru, T | 1 |
Hagiwara, K | 1 |
Matsuno, H | 1 |
Goto, A | 1 |
Oritsu, M | 1 |
Hamanaka, T | 1 |
Akiyama, O | 1 |
Bachta, A | 1 |
Tłustochowicz, M | 1 |
Pieramici, DJ | 1 |
Avery, RL | 1 |
Castellarin, AA | 1 |
Nasir, MA | 1 |
Rabena, M | 1 |
Fernández de Castro, LE | 1 |
Sarraf, OA | 1 |
Hawthorne, KM | 1 |
Vroman, DT | 1 |
Yoeruek, E | 1 |
Szurman, P | 1 |
Tatar, O | 1 |
Mittal, A | 1 |
Mittal, S | 1 |
Bharathi, JM | 1 |
Ramakrishnan, R | 1 |
Sathe, PS | 1 |
Ramasamy, B | 1 |
Quah, S | 1 |
Sahni, JN | 1 |
Palimar, P | 1 |
Cortez, MA | 1 |
Giuliari, GP | 1 |
Escaf, L | 1 |
Escaf, S | 1 |
Vidal, C | 1 |
Kelly, PJ | 1 |
Weiter, JJ | 1 |
O'Connor, GR | 1 |
Bolliger, GA | 1 |
Kupferman, A | 1 |
Leibowitz, HM | 1 |
Pavan-Langston, D | 1 |
Hettinger, ME | 1 |
Wilhelmus, KR | 1 |
Falcon, MG | 1 |
Jones, BR | 1 |
de Ancos, E | 1 |
Pittet, N | 1 |
Herbort, CP | 1 |
Schlote, T | 1 |
Dannecker, G | 1 |
Thiel, HJ | 1 |
Gray, T | 1 |
Kanski, J | 1 |
el-Harazi, SM | 1 |
Ruiz, RS | 1 |
Feldman, RM | 1 |
Villanueva, G | 1 |
Chuang, AZ | 1 |
Kent, AR | 1 |
Dubiner, HB | 1 |
Whitaker, R | 1 |
Mundorf, TK | 1 |
Stewart, JA | 1 |
Cate, EA | 1 |
Stewart, WC | 1 |
Fechtner, RD | 1 |
Khouri, AS | 1 |
Zimmerman, TJ | 1 |
Bullock, J | 1 |
Feldman, R | 1 |
Kulkarni, P | 1 |
Michael, AJ | 1 |
Realini, T | 1 |
Warwar, R | 1 |
Holland, GN | 1 |
Lappin, MR | 2 |
Black, JC | 1 |
Knox, CM | 1 |
Wong, IG | 1 |
Love, P | 1 |
Simone, JN | 1 |
Pendelton, RA | 1 |
Jenkins, JE | 1 |
Whitcup, SM | 1 |
Ferris, FL | 1 |
Esmaeli-Gutstein, B | 1 |
Winkelman, JZ | 1 |
Vantesone, DL | 1 |
Luna, JD | 1 |
Muiño, JC | 1 |
Juárez, CP | 1 |
Dodds, EM | 1 |
Meisler, DM | 1 |
Harada, T | 1 |
Akman, A | 1 |
Yücel, E | 1 |
Aydin, P | 1 |
Bhagat, N | 1 |
Read, RW | 1 |
Rao, NA | 1 |
Smith, RE | 1 |
Chong, LP | 1 |
Coombs, JM | 1 |
Durcan, FJ | 1 |
Struck, HG | 1 |
Bariszlovich, A | 1 |
Kolodny, NH | 1 |
Goode, ST | 1 |
Ryan, W | 1 |
Freddo, TF | 1 |
Bundschu, HD | 1 |
Chiou, GC | 1 |
Yao, QS | 1 |
Varma, RS | 1 |
English, RV | 1 |
Davidson, MG | 1 |
Nasisse, MP | 1 |
Jamieson, VE | 1 |
Yorston, D | 1 |
Foster, A | 1 |
Treharne, J | 1 |
Duker, JS | 1 |
Shields, JA | 1 |
Ross, M | 1 |
Newman, PE | 1 |
Beaver, PC | 1 |
Kozarsky, PE | 1 |
Waring, GO | 1 |
Pietruschka, G | 1 |
Hart, FD | 1 |
Singh, G | 1 |
Mathur, JS | 1 |
Kornreich, H | 1 |
Koster, K | 1 |
Hanson, V | 1 |
Cross, AG | 1 |
Ridley, H | 1 |
Merz, M | 1 |
Mika, T | 1 |
Lisowski, Z | 1 |
Prus-Sawicka, K | 1 |
Jütte, A | 1 |
Lemke, L | 1 |
Opitz, J | 1 |
Andersson, R | 1 |
Haga, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis[NCT02406209] | Phase 2 | 45 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum (MaPS in ENL[NCT03775460] | 550 participants (Anticipated) | Interventional | 2023-01-15 | Recruiting | |||
A Phase 3 Multicenter, Randomized, Double-Masked Study of the Safety and Efficacy of Difluprednate 0.05% Ophthalmic Emulsion Compared to Prednisolone Acetate 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis[NCT01201798] | Phase 3 | 111 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
Phase I/II Comparative Study of a Single Intraoperative Sub-Tenon's Capsule Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System Versus 1% Prednisolone and 0.3% Ciprofloxacin Eyedrops for Cataract Surgery[NCT00431028] | Phase 1/Phase 2 | 140 participants (Actual) | Interventional | 2005-09-30 | Terminated (stopped due to Terminated) | ||
A Double Blind Cross Over Clinical Trial to Determine Colchicine Efficacy in Behcet's Disease[NCT00700297] | Phase 2 | 169 participants (Actual) | Interventional | 2002-08-31 | Completed | ||
[NCT00501579] | Phase 3 | 0 participants | Interventional | Completed | |||
A Randomized, Masked Multi-center Safety & Efficacy Study of the Effects of Preoperative & Postoperative Cataract Surgery Use of Difluprednate Ophthalmic Emulsion, 0.05% Compared to Prednisolone Acetate Ophthalmic Suspension 1% on Visual Acuity & Corneal [NCT01244334] | Phase 4 | 52 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
A Comparison of a Single Orbital Floor Injection of Triamcinolone Versus Conventional Steroid and Antibiotic Drops Used Post Operatively in Uneventful Phacoemulsification Surgery[NCT00789971] | 150 participants (Actual) | Interventional | 2007-03-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Change from baseline comparison of NS2 ophthalmic drops (0.5%), NS2 (0.5%) and Pred Forte® (0.1%) ophthalmic drops, and Pred Forte® (1%) ophthalmic drops on an anterior chamber cell grade scale of 0 to 4 (0 = absent, 4 = severe). The least squares mean (standard error) was derived from analysis of covariance (ANCOVA) with baseline as a covariate and treatment group as a factor. (NCT02406209)
Timeframe: The efficacy assessment period was assessed at Week 8; baseline was Day 1.
Intervention | units on a scale (Least Squares Mean) |
---|---|
NS2 Ophthalmic Drops (0.5%) | -0.7 |
NS2 (0.5%) and Pred Forte® (0.1%) Ophthalmic Drops | -0.9 |
Pred Forte® (1%) Ophthalmic Drops | -0.5 |
Lack of efficacy was defined as those subjects who discontinued study participation either due to treatment failure or an adverse event with a preferred term of iridocyclitis, iritis, uveitis, or vitritis. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Time to Event
Intervention | Percentage of subjects (Number) |
---|---|
Durezol | 0 |
Pred Forte | 14.9 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = ≤ 1 cell count; 1 = 2 to 10 cell count; 2 = 11 to 20 cell count; 3 = 21 to 50 cell count; and 4 = > 50 cell count. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 21, Day 28, Day 35, Day 42
Intervention | Units on a scale (Mean) | ||||||
---|---|---|---|---|---|---|---|
Baseline (Day 0) | Day 3 | Day 7 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 2.6 | -1.1 | -1.8 | -2.4 | -2.3 | -2.3 | -2.3 |
Pred Forte | 2.6 | -1.0 | -1.6 | -2.1 | -2.1 | -2.1 | -2.1 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = ≤ 1 cell count; 1 = 2 to 10 cell count; 2 = 11 to 20 cell count; 3 = 21 to 50 cell count; and 4 = > 50 cell count. (NCT01201798)
Timeframe: Baseline (Day 0), Day 14
Intervention | Units on a scale (Mean) | |
---|---|---|
Baseline (Day 0) | Day 14 | |
Durezol | 2.6 | -2.2 |
Pred Forte | 2.6 | -2.0 |
Anterior chamber flare (protein escaping from dialated vessels) was assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = none; 1 = mild (trace to clearly noticeable, visible); 2 = moderate; 3 = marked; and 4 = severe. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
Intervention | Units on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Baseline (Day 0) | Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 2.2 | -1.1 | -1.6 | -2.0 | -2.0 | -2.0 | -2.0 | -2.0 |
Pred Forte | 2.3 | -1.2 | -1.6 | -1.9 | -2.0 | -2.0 | -2.0 | -2.0 |
The following signs were each graded on a 0 - 3 scale (0 = absent; 1 = mild; 2 = moderate; 3 = severe): posterior synechia, hypopyon, limbal injection, and keratic precipitates. Peripheral synechia was graded by the combined number of clock hours affected (0 = absent; 1 = < 3 hrs; 2 = 3-6 hours; 3 = > 6 hours). The total sign score was calculated as the sum of the 5 individual sign scores, the anterior chamber cell grade and the anterior chamber flare grade. The minimum/best total sign score was 0, and the maximum/worst total sign score was 23. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
Intervention | Units on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Baseline (Day 0) | Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 7.1 | -3.5 | -5.2 | -6.1 | -6.5 | -6.4 | -6.3 | -6.2 |
Pred Forte | 7.3 | -3.6 | -5.0 | -5.8 | -6.2 | -6.2 | -6.2 | -6.3 |
The following symptoms were each graded by the subject according to a 0-100 visual analog scale (VAS) using a mark on a 100 mm line (0 = absent, 100 = maximal): eye pain, photophobia, blurred vision, and lacrimation. The total symptom score was calculated as the sum of the 4 individual symptom scores. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
Intervention | Units on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Baseline (Day 0) | Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 186.7 | -88.4 | -108.2 | -133.3 | -138.8 | -140.1 | -143.9 | -146.2 |
Pred Forte | 203.2 | -88.4 | -123.8 | -137.4 | -149.5 | -152.4 | -147.3 | -155.5 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and recorded based on actual cell count. Anterior chamber flare (protein escaping from dialated vessels) was assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = none; 1 = mild (trace to clearly noticeable, visible); 2 = moderate; 3 = marked; and 4 = severe. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
Intervention | Percentage of subjects (Number) | ||||||
---|---|---|---|---|---|---|---|
Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 13.0 | 41.3 | 78.3 | 82.6 | 80.4 | 82.6 | 80.4 |
Pred Forte | 14.9 | 40.4 | 61.7 | 76.6 | 76.6 | 76.6 | 78.7 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and recorded based on actual cell count. Proportion is reported as a percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
Intervention | Percentage of subjects (Number) | ||||||
---|---|---|---|---|---|---|---|
Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 13.0 | 21.7 | 52.2 | 73.9 | 73.9 | 69.6 | 69.6 |
Pred Forte | 2.1 | 21.3 | 38.3 | 48.9 | 63.8 | 63.8 | 68.1 |
As assessed by the investigator during slit lamp examination. Anterior chamber cell grade was graded on a 5-point scale, with 0 = no cells; 1 = 1 to 10 cells; 2 = 11 to 20 cells; 3 = 21 to 50 cells; and 4 = more than 50 cells. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
Intervention | Percentage of subjects (Number) | ||||||
---|---|---|---|---|---|---|---|
Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 50.0 | 87.0 | 93.5 | 93.5 | 93.5 | 93.5 | 91.3 |
Pred Forte | 57.4 | 80.9 | 85.1 | 89.4 | 87.2 | 85.1 | 85.1 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = ≤ 1 cell count; 1 = 2 to 10 cell count; 2 = 11 to 20 cell count; 3 = 21 to 50 cell count; and 4 = > 50 cell count. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
Intervention | Percentage of subjects (Number) | ||||||
---|---|---|---|---|---|---|---|
Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
Durezol | 15.2 | 34.8 | 65.2 | 84.8 | 80.4 | 78.3 | 76.1 |
Pred Forte | 6.4 | 25.5 | 55.3 | 63.8 | 70.2 | 70.2 | 74.5 |
9 reviews available for prednisolone and Uveitis, Anterior
Article | Year |
---|---|
Two differing presentations of chronic bilateral anterior uveitis.
Topics: Aged, 80 and over; Chronic Disease; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Middle | 2009 |
Acute anterior uveitis.
Topics: Androstadienes; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cl | 2003 |
Acute anterior uveitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Humans; Ophthalmic | 2004 |
[Systemic management of autoimmune anterior uveitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; | 2005 |
Acute anterior uveitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Humans; Ophthalmic | 2005 |
New corticosteroids for the treatment of ocular inflammation.
Topics: Acute Disease; Androstadienes; Anti-Inflammatory Agents; Humans; Loteprednol Etabonate; Prednisolone | 1999 |
[Ocular complications in ulcerative colitis].
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Conjunctivitis; Diagnosis, Differential; Humans; Pred | 1999 |
[The clinical picture and therapy of sarcoidosis (Boeck's disease)].
Topics: Acute Disease; Adult; Chronic Disease; Diagnosis, Differential; Erythema Nodosum; Female; Humans; La | 1976 |
The rheumatic diseases in adolescence.
Topics: Adolescent; Adult; Antimalarials; Arthritis, Rheumatoid; Child; Child, Preschool; Dermatomyositis; D | 1973 |
26 trials available for prednisolone and Uveitis, Anterior
Article | Year |
---|---|
Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count | 2020 |
Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement.
Topics: Adult; Aged; Aminoquinolines; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocula | 2020 |
Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Benzophenones; Bromobenz | 2015 |
Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Cornea; Double-Blind Method; Eyelids; Fem | 2014 |
Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone.
Topics: Administration, Oral; Anterior Eye Segment; Cataract; Cataract Extraction; Cornea; Corneal Pachymetr | 2014 |
Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anterior Chamber; Anti-Inflammator | 2014 |
Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clonidine; Combined Modalit | 2015 |
Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
Topics: Administration, Topical; Aphakia, Postcataract; Cataract; Cataract Extraction; Child, Preschool; Dou | 2016 |
A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery.
Topics: Aged; Anterior Chamber; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Connective T | 2009 |
Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery.
Topics: Aged; Anti-Inflammatory Agents; Cataract Extraction; Cyclooxygenase Inhibitors; Diclofenac; Female; | 2010 |
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Behcet Syndrome; Cyclophosp | 2010 |
Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.
Topics: Adult; Anterior Chamber; Anti-Inflammatory Agents; Emulsions; Female; Fluprednisolone; Glucocorticoi | 2010 |
A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.
Topics: Aged; Aged, 80 and over; Cell Count; Cornea; Corneal Edema; Double-Blind Method; Endothelium, Cornea | 2011 |
Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anterior Chamber; Anti-Allergic Agents; Anti-Inflamm | 2013 |
Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
Topics: Azathioprine; Behcet Syndrome; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combina | 2003 |
Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery.
Topics: Double-Blind Method; Female; Glucocorticoids; Humans; Inflammation; Lens Implantation, Intraocular; | 2004 |
A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
Topics: Aged; Aged, 80 and over; Connective Tissue; Double-Blind Method; Female; Glucocorticoids; Humans; In | 2004 |
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; | 2005 |
Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis--a randomized triple masked study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Double-Blind Meth | 2004 |
A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; C | 1998 |
The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemotherapy, Adjuvant; Chr | 1998 |
Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; C | 1999 |
Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammatory Agents; | 1999 |
Effects of topical diclofenac and prednisolone eyedrops in laser in situ keratomileusis patients.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; C | 1999 |
Comparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgery.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Dexamethasone; Dr | 2001 |
An unusual uveitis in Tanzanian children.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Male; Prednisolone; Tanza | 1989 |
108 other studies available for prednisolone and Uveitis, Anterior
Article | Year |
---|---|
Oleander-Associated Keratitis and Uveitis.
Topics: Corneal Edema; Cyclopentolate; Female; Humans; Inflammation; Keratitis; Middle Aged; Moxifloxacin; N | 2022 |
Herpetic Keratouveitis following Intravitreal Ranibizumab Injection in a Case with Diabetic Macular Edema.
Topics: Angiogenesis Inhibitors; Antiviral Agents; Diabetic Retinopathy; Drug Therapy, Combination; Drug-Rel | 2021 |
Pharmacoproteomic analysis of topical dapsone and prednisolone interventions in the aqueous humor of anterior uveitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Dapsone; Disease Models, Ani | 2021 |
Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
Topics: Anti-Inflammatory Agents; Child; COVID-19; Humans; Male; Ophthalmic Solutions; Prednisolone; SARS-Co | 2021 |
Anterior Segment Injury by a High-Power Handheld Blue Laser Device.
Topics: Administration, Ophthalmic; Adolescent; Anterior Eye Segment; Atropine; Drug Therapy, Combination; E | 2018 |
Topics: Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Ophthalmic Solutions; Osteoporosis, Postmen | 2018 |
Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Aged, 80 and over; Brimonidine Tartrate; Conjun | 2018 |
Evaluation of changes in retinal and choroidal thickness using spectral domain optical coherence tomography in unilateral non granulomatous acute anterior uveitis.
Topics: Acute Disease; Adolescent; Adult; Choroid; Diabetic Retinopathy; Early Diagnosis; Female; Humans; Ma | 2019 |
Bilateral diffuse scleritis as a first manifestation of immunoglobulin G4-related sclerosing pachymeningitis.
Topics: Adult; Blood Sedimentation; Brain; C-Reactive Protein; Dexamethasone; Glucocorticoids; Humans; Immun | 2013 |
Reply: Evaluation of inflammation and intraocular pressure after cataract surgery.
Topics: Androstadienes; Anti-Allergic Agents; Cataract Extraction; Female; Glucocorticoids; Humans; Male; Po | 2013 |
Evaluation of inflammation and intraocular pressure after cataract surgery.
Topics: Androstadienes; Anti-Allergic Agents; Cataract Extraction; Female; Glucocorticoids; Humans; Male; Po | 2013 |
Association of bilateral acute anterior uveitis with a capsaicin patch.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Capsaicin; Female; Humans; Neck Pain; Ophthalmic Sol | 2013 |
[Hypopyon].
Topics: Administration, Ophthalmic; Ciliary Body; Diagnosis, Differential; Drug Therapy, Combination; Humans | 2012 |
Diagnostic ophthalmology. Anterior uveitis of the right eye.
Topics: Animals; Atropine; Female; Horse Diseases; Horses; Phenylbutazone; Prednisolone; Uveitis, Anterior | 2013 |
Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Capsule Opacification; Drug Therapy, Combination; Glucoco | 2013 |
Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment.
Topics: Animals; Anti-Inflammatory Agents; Biological Availability; Drug Carriers; Drug Compounding; Drug De | 2013 |
Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
Topics: Azathioprine; Behcet Syndrome; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Humans; | 2014 |
Acute retinal necrosis.
Topics: 2-Aminopurine; Antiviral Agents; Aqueous Humor; DNA, Viral; Eye Infections, Viral; Famciclovir; Fema | 2014 |
Toxic granulomatous anterior uveitis in live intracameral cysticercosis masquerading as leukocoria.
Topics: Anterior Chamber; Child; Combined Modality Therapy; Cysticercosis; Diagnosis, Differential; Eye Infe | 2014 |
New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; CTLA-4 Antigen; Female; Glucocorticoids; Humans | 2015 |
A case of herpes simplex keratouveitis diagnosed by real time polymerase chain reaction.
Topics: Acyclovir; Antiviral Agents; Aqueous Humor; DNA, Viral; Drug Therapy, Combination; Eye Infections, V | 2015 |
Multifocal choroiditis with panuveitis in an 8-year-old boy with long-standing idiopathic acute anterior uveitis.
Topics: Acute Disease; Administration, Topical; Arthritis, Juvenile; Child; Choroiditis; Drug Combinations; | 2016 |
Acute Mycoplasma pneumoniae infection presenting with unilateral anterior uveitis and perineuritis.
Topics: Acute Disease; Adolescent; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Magnetic Reso | 2016 |
Aggressive Initial Presentation of HLA-B27 Uveitis in Older Individuals: A Case Series.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Female; Glucocorticoids; HLA-B27 A | 2018 |
Cardiac sarcoidosis: a diagnostic puzzle.
Topics: Anti-Inflammatory Agents; Biopsy; Cardiac Imaging Techniques; Cardiomyopathies; Diagnosis, Different | 2016 |
Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: A Report of Three Cases.
Topics: Administration, Oral; Aged; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluoromethol | 2018 |
Secondary acute anterior uveitis with hyphema in a purpose-bred kitten.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; | 2008 |
Unilateral granulomatous post-streptococcal uveitis with elevated tension.
Topics: Adolescent; Anti-Inflammatory Agents; Antistreptolysin; Female; Granuloma; Humans; Intraocular Press | 2008 |
Non-necrotizing herpetic vasculitis.
Topics: Acyclovir; Aged; Antihypertensive Agents; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; G | 2009 |
Incidence and prognosis of ocular hypertension secondary to viral uveitis.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; F | 2010 |
Rifabutin-associated uveitis in an immunocompetent individual with Mycobacterium simiae.
Topics: Anti-Bacterial Agents; Glucocorticoids; Humans; Immunocompromised Host; Male; Middle Aged; Mycobacte | 2009 |
Recurrent anterior uveitis in Henoch Schonlein's vasculitis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; | 2010 |
Anterior uveitis as a clinical presentation of orbital inflammatory disease in an adult.
Topics: Adult; Diagnosis, Differential; Disease Progression; Humans; Inflammation; Male; Methylprednisolone; | 2009 |
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids.
Topics: Administration, Topical; Adolescent; Adult; Arthritis, Juvenile; Cataract; Child; Child, Preschool; | 2010 |
Tubulointerstitial nephritis and uveitis in siblings.
Topics: Administration, Topical; Adolescent; Alleles; Drug Administration Schedule; Female; Genetic Linkage; | 2010 |
Intracameral triamcinolone acetonide after pediatric cataract surgery.
Topics: Administration, Topical; Adolescent; Anterior Chamber; Cataract Extraction; Child; Child, Preschool; | 2010 |
Anterior uveitis associated with high-dose cytosine arabinoside.
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Cytarabine; Dose-Response Rel | 2010 |
Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; | 2011 |
Presumed dengue-associated immune-mediated uveitis.
Topics: Dengue; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Prednisolone; Triamcinolone Aceton | 2011 |
[Post-streptococcal uveitis].
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Antistreptolysin; Female; Fluorescein A | 2011 |
Bilateral, simultaneous, uveitis-associated pupillary membranes.
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Humans; Male; Middle Aged; Ophthalmologic Surgi | 2011 |
Immune ring formation associated with cytomegalovirus endotheliitis.
Topics: Administration, Topical; Adult; Antiviral Agents; Aqueous Humor; Cytomegalovirus; Cytomegalovirus In | 2011 |
Acute anterior uveitis and optic neuritis as ocular complications of influenza A infection in an 11-year-old boy.
Topics: Acute Disease; Administration, Topical; Antiviral Agents; Child; Drug Therapy, Combination; Fluoresc | 2011 |
Recurrent iris cyst discharge.
Topics: Administration, Topical; Cysts; Exfoliation Syndrome; Female; Glucocorticoids; Humans; Intraocular P | 2012 |
Long-term follow-up of inflammatory cystoid macular edema.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Gluc | 2012 |
Uveitis exacerbation after varicella-zoster vaccination in an adult.
Topics: Acyclovir; Aged, 80 and over; Antiviral Agents; Cell Count; Corneal Edema; Drug Therapy, Combination | 2012 |
Bilateral severe anterior uveitis after unilateral selective laser trabeculoplasty.
Topics: Adult; Anterior Chamber; Cyclopentolate; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Gl | 2013 |
Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
Topics: Acute Disease; Blood Sedimentation; Bone Density Conservation Agents; C-Reactive Protein; Dexamethas | 2012 |
Acute exacerbation of ankylosing spondylitis after chlamydial infection in a patient well-controlled with etanercept.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthrit | 2012 |
Effects of gold nanoparticles on endotoxin-induced uveitis in rats.
Topics: Administration, Topical; Animals; Aqueous Humor; Blotting, Western; Disease Models, Animal; Endotoxi | 2012 |
Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism.
Topics: Aged; Anti-Inflammatory Agents; Cyclopentolate; Diagnosis, Differential; Female; Histiocytosis, Sinu | 2002 |
Anterior uveitis and Sjögren's syndrome in a patient with primary biliary cirrhosis.
Topics: Administration, Topical; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Middle | 2002 |
Endogenous fungal retinitis in a patient with acute lymphocytic leukemia manifesting as uveitis and optic nerve lesion.
Topics: Antineoplastic Agents; Child, Preschool; Eye Enucleation; Eye Infections, Fungal; Glucocorticoids; H | 2002 |
Sectorial keratitis and uveitis: differential diagnosis.
Topics: Acyclovir; Administration, Topical; Adult; Anti-Inflammatory Agents; Antiviral Agents; Corneal Strom | 2003 |
Vitritis and chorioretinitis in a patient with West Nile virus infection.
Topics: Anti-Infective Agents; Antibodies, Viral; Chorioretinitis; Drug Therapy, Combination; Eye Diseases; | 2003 |
Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination.
Topics: Acyclovir; Antiviral Agents; Chickenpox Vaccine; Child; Cyclopentolate; DNA, Viral; Drug Therapy, Co | 2003 |
Recurrent anterior uveitis and healed retinal vasculitis associated with multiple sclerosis.
Topics: Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Predni | 2003 |
Tubulointerstitial nephritis and uveitis syndrome.
Topics: Adolescent; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Nephritis, Interstitial; Paras | 2003 |
Rosai-Dorfman disease with bilateral serous retinal detachment.
Topics: Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Histiocytosis, Sinus; Humans; Immunosuppre | 2003 |
Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo.
Topics: Animals; Antioxidants; Aqueous Humor; beta Carotene; Cell Count; Cell Line; Cell Survival; Dinoprost | 2003 |
Anterior uveitis in a child with Takayasu's arteritis.
Topics: Child; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressiv | 2004 |
Recurrent anterior uveitis in patients with Vogt-Koyanagi-Harada syndrome.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Age | 2004 |
Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Con | 2004 |
Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis.
Topics: Animals; Anti-Inflammatory Agents; Aqueous Humor; Blotting, Western; Cell Line; Cyclooxygenase 2; Di | 2005 |
Comparison of topical steroids for acute anterior uveitis.
Topics: Acute Disease; Administration, Topical; Androstadienes; Animals; Aqueous Humor; Blotting, Western; C | 2004 |
Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Aqueous Humor; Blotting, Western; Cells, Cultured; Culture Media; | 2005 |
Uveitis-associated flap edema and lamellar interface fluid collection after LASIK.
Topics: Acute Disease; Body Fluids; Corneal Edema; Corneal Stroma; Female; Glucocorticoids; Humans; Hyperopi | 2005 |
A case of tubulointerstitial nephritis and uveitis syndrome with severe immunologic dysregulation.
Topics: Acute Disease; Autoantibodies; beta 2-Microglobulin; Biopsy; CD4-Positive T-Lymphocytes; Child; Cycl | 2005 |
Exogenous Cushing's syndrome and topical ocular steroids.
Topics: Adolescent; Cushing Syndrome; Glucocorticoids; Humans; Male; Ophthalmic Solutions; Prednisolone; Uve | 2006 |
Anterior uveitis and iris nodules that are associated with Langerhans cell histiocytosis.
Topics: Adolescent; Diagnosis, Differential; Glucocorticoids; Hemorrhage; Histiocytosis, Langerhans-Cell; Hu | 2005 |
Sarcoidosis with acute recurrent polyarthritis and hypercalcemia.
Topics: Acute Disease; Arthritis; Dizziness; Female; Gallium Radioisotopes; Glucocorticoids; Humans; Hyperca | 2006 |
Case of anterior uveitis after intravitreal injection of bevacizumab.
Topics: Aged; Angiogenesis Inhibitors; Anterior Eye Segment; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2006 |
Ocular manifestations after primary varicella infection.
Topics: Chickenpox; Child; Diagnosis, Differential; Follow-Up Studies; Glucocorticoids; Humans; Keratitis; M | 2006 |
[Scleromalacia associated with varicella-zoster virus].
Topics: Acyclovir; Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory Agents; Antiviral | 2008 |
Uveitis during outbreak of Chikungunya fever.
Topics: Adult; Aged; Alphavirus Infections; Antihypertensive Agents; Chikungunya virus; Cyclopentolate; Dise | 2007 |
Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
Topics: Acute Disease; Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density Co | 2007 |
Ocular cysticercosis of the anterior segment.
Topics: Animals; Anterior Eye Segment; Aza Compounds; Child; Cysticercosis; Cysticercus; Drug Therapy, Combi | 2007 |
Resolution of optic disk neovascularization associated with intraocular inflammation.
Topics: Adult; Child; Dexamethasone; Female; Humans; Middle Aged; Neovascularization, Pathologic; Ophthalmic | 1980 |
Ocular sarcoidosis.
Topics: Eye Diseases; Humans; Prednisolone; Sarcoidosis; Uveitis, Anterior | 1983 |
Quantitation of anterior chamber inflammation and its response to therapy.
Topics: Animals; Anterior Chamber; Eye; Female; Inflammation; Male; Prednisolone; Rabbits; Uveitis; Uveitis, | 1980 |
Ocular herpes: an update.
Topics: Antiviral Agents; Basement Membrane; Humans; Keratitis; Keratitis, Dendritic; Prednisolone; Recurren | 1981 |
Herpetic iridocyclitis.
Topics: Acyclovir; Administration, Topical; Adolescent; Adult; Female; Guanine; Humans; Idoxuridine; Intraoc | 1982 |
[Quantitative measurement of inflammation in HLA-B27 acute anterior uveitis using the Kowa FC-100 laser flare-cell meter].
Topics: Acute Disease; Arthritis, Reactive; Drug Therapy, Combination; HLA-B27 Antigen; Humans; Lasers; Opht | 1994 |
[Cyclosporin A in therapy of chronic uveitis in childhood].
Topics: Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedul | 1996 |
Steroid responsive disc neovascularisation in uveitis associated with juvenile chronic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Child, Preschool; Chronic Disease; Female | 1998 |
Anterior uveitis associated with latanoprost.
Topics: Administration, Topical; Adult; Aged; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraoc | 1998 |
Recurrent anterior uveitis associated with streptococcal pharyngitis in a patient with a history of poststreptococcal syndrome.
Topics: Adolescent; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Pharyngitis; Prednisolone; | 1999 |
Bartonella spp infection as a possible cause of uveitis in a cat.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Bacteria | 1999 |
Chronic uveitis following a streptococcal illness.
Topics: Chronic Disease; Eye Infections, Bacterial; Glucocorticoids; Humans; Male; Methotrexate; Middle Aged | 1999 |
Uveitis associated with varicella virus vaccine.
Topics: Acyclovir; Adolescent; Anterior Eye Segment; Chickenpox Vaccine; Drug Therapy, Combination; Female; | 1999 |
Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Inflammatory A | 1999 |
Granulomatous anterior uveitis in a patient with CREST syndrome.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; CREST Syndrome; Cyclopentolate; Drug Therap | 2000 |
Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diagnosis, Di | 2001 |
Postoperative inflammation in a patient with multiple sclerosis.
Topics: Acute Disease; Female; Glucocorticoids; Humans; Lens Implantation, Intraocular; Middle Aged; Multipl | 2001 |
Evaluation of therapeutic effectiveness using MR imaging in a rabbit model of anterior uveitis.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents; Ciliary Body; Contrast Media; Disease Models, A | 2002 |
Inhibition of ocular inflammation by chalcone derivatives and prednisolone.
Topics: Animals; Chalcone; Crystallins; Endotoxins; Female; Injections, Intraperitoneal; Male; Ophthalmic So | 1992 |
Intraocular disease associated with feline immunodeficiency virus infection in cats.
Topics: Animals; Atropine; Cat Diseases; Cats; Eye Infections; Glaucoma; Immunologic Deficiency Syndromes; P | 1990 |
Intraocular large cell lymphoma presenting as massive thickening of the uveal tract.
Topics: Diagnosis, Differential; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Predniso | 1987 |
Fly larva adherent to corneal endothelium.
Topics: Adult; Corneal Diseases; Diptera; Eye Foreign Bodies; Humans; Larva; Male; Prednisolone; Uveitis, An | 1986 |
[Contribution on the clinical problems of idiopathic panuveitis (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Azathioprine; Child; Child, Preschool; Chorioretinit | 1974 |
Ankylosing spondylitis.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Arthritis, Juvenile; Arthritis, Reactive; Colitis, Ul | 1968 |
Atopic erythroderma with bilateral cataract, unilateral keratoconus and iridocyclitis, and undescended testes.
Topics: Adolescent; Cataract; Cryptorchidism; Dermatitis, Atopic; Dermatitis, Exfoliative; Diet Therapy; Hum | 1968 |
Uveitis in children.
Topics: Adolescent; Arthritis, Juvenile; Behcet Syndrome; Blindness; Cataract; Child; Child, Preschool; Eye | 1965 |
Cataract surgery in chronic uveitis.
Topics: Adrenal Cortex Hormones; Cataract; Cataract Extraction; Humans; Prednisolone; Uveitis; Uveitis, Ante | 1965 |
[Therapeutic trial using iontophoresis of Solu-Dacortin in certain eye diseases].
Topics: Eye Diseases; Humans; Iontophoresis; Iritis; Optic Neuritis; Prednisolone; Succinates; Uveitis; Uvei | 1969 |
Clinical investigations on the effect of glucocorticoids on intraocular tension.
Topics: Adolescent; Adult; Aged; Chorioretinitis; Humans; Intraocular Pressure; Middle Aged; Prednisolone; P | 1969 |
[Chronic cyclitis in children].
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Ciliary Body; Cortisone; Fluoresceins; Fundus | 1969 |
[Clinically manifest muscular sarcoidosis].
Topics: Adult; Blood Protein Disorders; Calcium Metabolism Disorders; Female; Humans; Lymphadenitis; Muscula | 1965 |